FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Bayer HealthCare Pharmaceuticals Medroxyprogesterone acetate Recall

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx…

Bayer HealthCare Pharmaceuticals Inc. · Morristown, NJ

Risk level
Class III
Reported by FDA
Jul 24, 2013
Recall ID
D-807-2013
Check your lot numberHow we source this data

Summary

Bayer HealthCare Pharmaceuticals recalled Medroxyprogesterone acetate starting Jun 13, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-807-2013 on Jul 24, 2013. Reason: Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point. Status: Terminated.

Why it was recalled

Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.

Product description

Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin

Lot numbers, UPCs & expiration codes

Lot 87100040

Where it was sold

NY, CA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-807-2013
Classification
Class III
Status
Terminated
Recall initiated
Jun 13, 2013
FDA report date
Jul 24, 2013
Quantity
194.62 kg
Recall type
Voluntary: Firm initiated
Recalling firm
Bayer HealthCare Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-807-2013, exactly as published.

Show all FDA fields
City
Morristown
State
NJ
Status
Terminated
Country
United States
Event ID
65702
Address
36 Columbia Rd
Code information
Lot 87100040
Postal code
07960-4526
Report date
Jul 24, 2013
Product type
Drugs
Recall number
D-807-2013
Classification
Class III
Recalling firm
Bayer HealthCare Pharmaceuticals Inc.
Product quantity
194.62 kg
Termination date
Feb 10, 2014
Reason for recall
Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin
Distribution pattern
NY, CA
Recall initiation date
Jun 13, 2013
Initial firm notification
Letter
Center classification date
Jul 18, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-807-2013, published Jul 24, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls